Top compounds associated with response to PRAMEF19


Feature Type Standardized
Nominal ANOVA
mRNA lovastatin CTRPv2 pan-cancer AAC -0.081 0.02
mRNA STF-62247 GDSC1000 pan-cancer AAC 0.072 0.02
mRNA CCT018159 GDSC1000 pan-cancer AAC 0.075 0.03
mRNA masitinib CTRPv2 pan-cancer AAC 0.08 0.03
mRNA ciclosporin CTRPv2 pan-cancer AAC 0.081 0.03
mRNA PL-DI CTRPv2 pan-cancer AAC -0.066 0.03
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.065 0.03
mRNA MG-132 GDSC1000 pan-cancer AAC -0.1 0.04
mRNA PD-0325901 GDSC1000 pan-cancer AAC -0.066 0.04
mRNA YL54 CTRPv2 pan-cancer AAC 0.08 0.04
Download CSV